Dogwood Therapeutics, Inc.
DWTX
$1.94
-$0.10-4.90%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -34.69% | -33.15% | -29.83% | 128.78% | 200.18% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 62.27% | 86.37% | 128.74% | 444.45% | 279.38% |
| Operating Income | -62.27% | -86.37% | -128.74% | -444.45% | -279.38% |
| Income Before Tax | -56.78% | -29.80% | -175.59% | -564.04% | -424.65% |
| Income Tax Expenses | -1,388.32% | -83.32% | 44,300.00% | -- | -- |
| Earnings from Continuing Operations | -45.67% | -28.82% | -177.39% | -567.33% | -428.72% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -45.67% | -28.82% | -177.39% | -567.33% | -428.72% |
| EBIT | -62.27% | -86.37% | -128.74% | -444.45% | -279.38% |
| EBITDA | -86.19% | -139.10% | -270.52% | -- | -- |
| EPS Basic | 52.36% | 40.89% | -69.32% | -295.24% | -219.94% |
| Normalized Basic EPS | 33.37% | 13.72% | -26.65% | -205.68% | -123.70% |
| EPS Diluted | 52.36% | 40.89% | -69.32% | -295.24% | -219.94% |
| Normalized Diluted EPS | 33.37% | 13.72% | -26.65% | -205.68% | -123.70% |
| Average Basic Shares Outstanding | 1,356.94% | 986.09% | 381.93% | 84.54% | 79.28% |
| Average Diluted Shares Outstanding | 1,356.94% | 986.09% | 381.93% | 84.54% | 79.28% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |